Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines.

LNCaP T-47D) clonogenic assay external photon beam (X-ray) human cancer cell lines (PC-3 multicellular tumor spheroids (3D) radiation oncology radiobiology radiosensitivity resazurin assay therapy γH2AX

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
18 01 2023
Historique:
received: 21 11 2022
revised: 10 01 2023
accepted: 16 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Radiation therapy is one of the most effective tools in cancer therapy. However, success varies individually, necessitating improved understanding of radiobiology. Three-dimensional (3D) tumor spheroids are increasingly gaining attention, being a superior in vitro cancer model compared to 2D cell cultures. This in vitro study aimed at comparing radiation responses in 2D and 3D cell culture models of different human cancer cell lines (PC-3, LNCaP and T-47D) irradiated with varying doses (1, 2, 4, 6, 8 or 20 Gy) of X-ray beams. Radiation response was analyzed by growth analysis, various cell viability assays (e.g., clonogenic assay, resazurin assay) and amount of DNA damage (γH2AX Western Blot). Results showed decreasing cell proliferation with the increase of radiation doses for all cell lines in monolayers and spheroids of LNCaP and T-47D. However, significantly lower radiosensitivity was detected in spheroids, most pronounced in PC-3, evincing radiation resistance of PC-3 spheroids up to 8 Gy and significant growth inhibition only by a dose escalation of 20 Gy. Cell line comparison showed highest radiosensitivity in LNCaP, followed by T-47D and PC-3 in 2D, whereas, in 3D, T-47D showed highest sensitivity. The results substantiate the significant differences in radiobiological response to X-rays between 2D and 3D cell culture models.

Identifiants

pubmed: 36766704
pii: cells12030360
doi: 10.3390/cells12030360
pmc: PMC9913494
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cytotherapy. 2011 Sep;13(8):1000-12
pubmed: 21619419
Biotechnol J. 2008 Oct;3(9-10):1172-84
pubmed: 18566957
Front Mol Biosci. 2020 Mar 06;7:33
pubmed: 32211418
Int J Mol Sci. 2020 Sep 16;21(18):
pubmed: 32948069
Sci Rep. 2020 Feb 3;10(1):1653
pubmed: 32015396
Biotechnol Adv. 2016 Dec;34(8):1427-1441
pubmed: 27845258
Nat Nanotechnol. 2010 Apr;5(4):291-6
pubmed: 20228788
Br J Cancer Suppl. 1984;6:203-6
pubmed: 6582906
Int J Radiat Oncol Biol Phys. 1986 Jun;12(6):975-82
pubmed: 3721939
Cancer Metastasis Rev. 1994 Jun;13(2):121-38
pubmed: 7923546
Arch Med Sci. 2018 Jun;14(4):910-919
pubmed: 30002710
Int J Radiat Biol. 1999 Jul;75(7):787-99
pubmed: 10489890
Radiother Oncol. 1993 Mar;26(3):264-70
pubmed: 8316657
Analyst. 2011 Feb 7;136(3):473-8
pubmed: 20967331
Polymers (Basel). 2020 Oct 28;12(11):
pubmed: 33126468
PLoS One. 2021 Jan 4;16(1):e0244513
pubmed: 33395433
Nat Protoc. 2006;1(5):2315-9
pubmed: 17406473
J R Soc Interface. 2017 Feb;14(127):
pubmed: 28202590
Exp Cell Res. 1972 Mar;71(1):75-80
pubmed: 5063574
Z Med Phys. 2014 Dec;24(4):363-72
pubmed: 25270978

Auteurs

Julia Raitanen (J)

Ludwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.
Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Vienna Doctoral School of Chemistry (DoSChem), University of Vienna, 1090 Vienna, Austria.
Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.

Bernadette Barta (B)

Ludwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.

Marcus Hacker (M)

Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria.

Dietmar Georg (D)

Department of Radiation Oncology, Division of Medical Radiation Physics, Medical University of Vienna, 1090 Vienna, Austria.

Theresa Balber (T)

Ludwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.
Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria.

Markus Mitterhauser (M)

Ludwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.
Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH